NEW YORK (GenomeWeb News) – Helicos BioSciences has filed a prospectus with the US Securities and Exchange Commission on behalf of selling shareholders offering around 6.6 million shares of the firm's common stock.

The firm will offer the resale from time to time of up to 6,633,789 shares of its common stock, with 2,322,509 of those shares issuable upon exercise of warrants. Helicos is not selling any securities in the offering and will not receive any of the proceeds from the selling shareholders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.